A higher IDO expression level is favorable for patients with RCC treated with immunotherapy, but it is not yet known if the interferon treatment is increasing the IDO level or if the IDO level has a significant effect on the response of the patients [49]. Here, IDO1 is linked to renal cell carcinoma.